These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31726474)

  • 21. [Epidemiology of hepatocellular carcinoma].
    Okuda K
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1105-15. PubMed ID: 8751796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
    Kirk GD; Lesi OA; Mendy M; Akano AO; Sam O; Goedert JJ; Hainaut P; Hall AJ; Whittle H; Montesano R
    Hepatology; 2004 Jan; 39(1):211-9. PubMed ID: 14752840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological characteristics and risk factors of hepatocellular carcinoma.
    Chen CJ; Yu MW; Liaw YF
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S294-308. PubMed ID: 9407350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of hepatocellular carcinoma.
    Yu MC; Yuan JM; Govindarajan S; Ross RK
    Can J Gastroenterol; 2000 Sep; 14(8):703-9. PubMed ID: 11185536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma: paradigm of preventive oncology.
    O'Brien TR; Kirk G; Zhang M
    Cancer J; 2004; 10(2):67-73. PubMed ID: 15130266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of hepatocellular carcinoma.
    Sherman M
    Oncology; 2010 Jul; 78 Suppl 1():7-10. PubMed ID: 20616577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of digestive tract cancers in India. III. Liver.
    Dhir V; Mohandas KM
    Indian J Gastroenterol; 1998; 17(3):100-3. PubMed ID: 9695391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of aflatoxins and hepatitis viruses in the etiopathogenesis of hepatocellular carcinoma: A basis for primary prevention in Guinea-Conakry, West Africa.
    Turner PC; Sylla A; Diallo MS; Castegnaro JJ; Hall AJ; Wild CP
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S441-8. PubMed ID: 12534775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between hepatitis B virus infection and exposure to aflatoxins in the development of hepatocellular carcinoma: a molecular epidemiological approach.
    Sylla A; Diallo MS; Castegnaro J; Wild CP
    Mutat Res; 1999 Jul; 428(1-2):187-96. PubMed ID: 10517992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.
    Liu Y; Wu F
    Environ Health Perspect; 2010 Jun; 118(6):818-24. PubMed ID: 20172840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region.
    Zhu RX; Seto WK; Lai CL; Yuen MF
    Gut Liver; 2016 May; 10(3):332-9. PubMed ID: 27114433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma and African iron overload.
    Gangaidzo IT; Gordeuk VR
    Gut; 1995 Nov; 37(5):727-30. PubMed ID: 8549953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of hepatocellular carcinoma.
    Kew MC
    Ann Hepatol; 2010; 9(2):120-32. PubMed ID: 20526004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.
    Seeff LB; Hoofnagle JH
    Oncogene; 2006 Jun; 25(27):3771-7. PubMed ID: 16799618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.
    Venook AP; Papandreou C; Furuse J; de Guevara LL
    Oncologist; 2010; 15 Suppl 4():5-13. PubMed ID: 21115576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma.
    Omer RE; Kuijsten A; Kadaru AM; Kok FJ; Idris MO; El Khidir IM; van 't Veer P
    Nutr Cancer; 2004; 48(1):15-21. PubMed ID: 15203373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.
    Hatzakis A; Van Damme P; Alcorn K; Gore C; Benazzouz M; Berkane S; Buti M; Carballo M; Cortes Martins H; Deuffic-Burban S; Dominguez A; Donoghoe M; Elzouki AN; Ben-Alaya Bouafif N; Esmat G; Esteban R; Fabri M; Fenton K; Goldberg D; Goulis I; Hadjichristodoulou C; Hatzigeorgiou T; Hamouda O; Hasurdjiev S; Hughes S; Kautz A; Malik M; Manolakopoulos S; Matičič M; Papatheodoridis G; Peck R; Peterle A; Potamitis G; Prati D; Roudot-Thoraval F; Reic T; Sharara A; Shennak M; Shiha G; Shouval D; Sočan M; Thomas H; Thursz M; Tosti M; Trépo C; Vince A; Vounou E; Wiessing L; Manns M
    J Viral Hepat; 2013 Aug; 20 Suppl 2():1-20. PubMed ID: 23827008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.